Nitric oxide synthesis in rat cardiac myocytes and fibroblasts

Life Sci. 1994;55(14):1101-8. doi: 10.1016/0024-3205(94)00238-x.

Abstract

We investigated nitric oxide (NO) synthase activity in cultured neonatal rat cardiac myocytes and fibroblasts upon treatment with interleukin 1 beta (IL-1 beta) and lipopolysaccharide (LPS). Incubation of cardiac myocytes for 24 h with IL-1 beta or LPS caused a significant increase in NO and cGMP production. Simultaneous incubation of IL-1 beta with NG-monomethyl-L-arginine or transforming growth factor beta (TGF-beta) completely inhibited the IL-1 beta-induced NO and cGMP production in cardiac myocytes. In contrast, incubation of cardiac fibroblasts for 24 h with IL-1 beta or LPS showed no significant effect on NO or cGMP production. Addition of IL-1 beta decreased the beating rate of cardiac myocytes, but TGF-beta overcame that inhibition. These observations suggest the presence of iNOS in cardiac myocytes, which is an important regulator of contractile function of the heart.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Oxidoreductases / metabolism
  • Animals
  • Cells, Cultured
  • Cyclic GMP / biosynthesis
  • Fibroblasts / enzymology
  • Fibroblasts / metabolism*
  • Heart / drug effects
  • Interleukin-1 / pharmacology
  • Kinetics
  • Lipopolysaccharides / pharmacology
  • Myocardium / cytology
  • Myocardium / enzymology
  • Myocardium / metabolism*
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide Synthase
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Interleukin-1
  • Lipopolysaccharides
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Amino Acid Oxidoreductases
  • Cyclic GMP